A recent study indicates that people who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Findings released in a prominent medical journal shows that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Users purchasing such drugs should be cognizant of the danger of rapid rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a reversion to original mass within about one and a half years.
Analyzing Treatments
The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Researchers point out that people who lose weight through dieting generally have a more gradual weight regain—perhaps 100 grams monthly—after stopping.
The Reason for the Rapid Rebound
Nutrition scientists propose the mode of action of the jabs accounts for the accelerated weight return.
The injections imitate a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in appetite is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Health authorities advise the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, considering the high risk of weight regain, the therapy should be considered ongoing.
This view is echoed by drug manufacturers, who note that the findings "highlight the persistent nature of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Individuals who have stopped the jabs describe a intense return of hunger.
"It felt as if a trigger activating and I was suddenly ravenous," described an individual.
The struggle is worsened if patients have not established lasting dietary or behavioural modifications during therapy.
Significant Adoption
Survey data suggest that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is greater among women compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are potent tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on integrated lifestyle changes.
